Evaluation of clinical and laboratory predictors of fatality in patients with Hantavirus infection

Volume: 2 Number: 04 December 1, 2012
  • Uğur Kostakoglu
  • Gürdal Yılmaz
  • Serkan Volkan
  • Sevinc Kant Sökel
  • Selcuk Kaya
  • Iftihar Köksal
TR EN

Evaluation of clinical and laboratory predictors of fatality in patients with Hantavirus infection

Abstract

Objectives: To determine the clinical and laboratory predictors of fatality among patients with Hantavirus infection. Material and methods: A retrospective study was conducted on the patients with Hantavirus infection between April 2009 and October 2011 at the Black Sea and the Mediterranean regions in Turkey. Demographic, clinical and laboratory findings of fatal cases and non-fatal cases at the admission were compared. Results: Twenty-two patients with confirmed Hantavirus infection were evaluated. Five patients died (22.7%). The cause of death was massive bleeding. The rate of hemorrhage was significantly higher in the fatal cases than non-fatal cases (p<0.001). Massive gastrointestinal hemorrhage was seen in four of these patients, cerebral hemorrhage in two and both gastrointestinal and pulmonary hemorrhage in one. Disseminated intravascular coagulation (DIC) was present in four of the fatal cases and a remarkable cause of the bleeding (p=0.02). White blood cell count (WBC) (p=0.002), creatine phosphokinase (CPK) (p=0.011), blood-urea-nitrogen (BUN) (p=0.014), C reactive protein (CRP) (p=0.005) and D-dimer levels (p=0.001), prothrombin time (PT) (p=0.023), activated partial thromboplastin time (aPTT) (p=0.001) and international normalized ratio (INR) (p=0.021) were significantly higher, and platelet counts (p=0.038) significantly lower in the fatal cases. Optimum diagnostic cut-off points for specific laboratory parameters which may be predictive of fatality were; WBC=16,000 &micro;L-1, PLT=30000 &micro;L-1, PT=19.7 s, aPTT=36 s, INR=1.2, D-dimer=9.3 &micro;g/mL, CPK=600 U/L, BUN=47 mg/dL and CRP=13.4 mg/dL. Conclusions: Physicians should be aware of the high fatality risk for patients with Hantavirus infection with hemorrhage, elevated WBC, CPK, BUN, CRP, PT, aPTT, INR and D-dimer and reduced platelet counts.

Keywords

References

  1. Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Mi- crobiol Rev 2010; 23:412-441.
  2. Song, G. Epidemiological progresses of hemorrhagic fever with renal syndrome in China. Chin Med J (Engl.) 1999; 112:472-477.
  3. Heyman P, Vaheri A, Lundkvist A, Avsic-Zupanc T. Hantavirus infections in Europe: from virus carriers to a major public- health problem. Expert Rev Anti Infect Ther 2009; 7:205-217.
  4. Heyman P, Vaheri A; ENIVD Members. Situation of hantavi- rus infections and haemorrhagic fever with renal syndrome in European countries as of December 2006. Euro Surveill 2008; 13 (28). pii: 18925.
  5. Simpson SQ, Spikes L, Patel S, Faruqi I. Hantavirus pulmo- nary syndrome. Infect Dis Clin North Am 2010; 24:159-173.
  6. Muranyi W, Bahr U, Zeier M, van der Woude FJ. Hantavirus infection. J Am Soc Nephrol 2005; 16:3669-3679.
  7. Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A. Hantavirus infections in Europe. Lancet Infect Dis 2003;3:653-661.
  8. Ertek M, Buzgan T; Refik Saydam National Public Health Agency. An outbreak caused by Hantavirus in the Black Sea Region of Turkey, January-May 2009. Euro Surveill 2009; 14(20).

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

-

Authors

Uğur Kostakoglu This is me

Gürdal Yılmaz This is me

Serkan Volkan This is me

Sevinc Kant Sökel This is me

Selcuk Kaya This is me

Iftihar Köksal This is me

Publication Date

December 1, 2012

Submission Date

January 30, 2015

Acceptance Date

-

Published in Issue

Year 2012 Volume: 2 Number: 04

APA
Kostakoglu, U., Yılmaz, G., Volkan, S., Sökel, S. K., Kaya, S., & Köksal, I. (2012). Evaluation of clinical and laboratory predictors of fatality in patients with Hantavirus infection. Journal of Microbiology and Infectious Diseases, 2(04), 155-159. https://doi.org/10.5799/jmid.123129
AMA
1.Kostakoglu U, Yılmaz G, Volkan S, Sökel SK, Kaya S, Köksal I. Evaluation of clinical and laboratory predictors of fatality in patients with Hantavirus infection. J Microbil Infect Dis. 2012;2(04):155-159. doi:10.5799/jmid.123129
Chicago
Kostakoglu, Uğur, Gürdal Yılmaz, Serkan Volkan, Sevinc Kant Sökel, Selcuk Kaya, and Iftihar Köksal. 2012. “Evaluation of Clinical and Laboratory Predictors of Fatality in Patients With Hantavirus Infection”. Journal of Microbiology and Infectious Diseases 2 (04): 155-59. https://doi.org/10.5799/jmid.123129.
EndNote
Kostakoglu U, Yılmaz G, Volkan S, Sökel SK, Kaya S, Köksal I (December 1, 2012) Evaluation of clinical and laboratory predictors of fatality in patients with Hantavirus infection. Journal of Microbiology and Infectious Diseases 2 04 155–159.
IEEE
[1]U. Kostakoglu, G. Yılmaz, S. Volkan, S. K. Sökel, S. Kaya, and I. Köksal, “Evaluation of clinical and laboratory predictors of fatality in patients with Hantavirus infection”, J Microbil Infect Dis, vol. 2, no. 04, pp. 155–159, Dec. 2012, doi: 10.5799/jmid.123129.
ISNAD
Kostakoglu, Uğur - Yılmaz, Gürdal - Volkan, Serkan - Sökel, Sevinc Kant - Kaya, Selcuk - Köksal, Iftihar. “Evaluation of Clinical and Laboratory Predictors of Fatality in Patients With Hantavirus Infection”. Journal of Microbiology and Infectious Diseases 2/04 (December 1, 2012): 155-159. https://doi.org/10.5799/jmid.123129.
JAMA
1.Kostakoglu U, Yılmaz G, Volkan S, Sökel SK, Kaya S, Köksal I. Evaluation of clinical and laboratory predictors of fatality in patients with Hantavirus infection. J Microbil Infect Dis. 2012;2:155–159.
MLA
Kostakoglu, Uğur, et al. “Evaluation of Clinical and Laboratory Predictors of Fatality in Patients With Hantavirus Infection”. Journal of Microbiology and Infectious Diseases, vol. 2, no. 04, Dec. 2012, pp. 155-9, doi:10.5799/jmid.123129.
Vancouver
1.Uğur Kostakoglu, Gürdal Yılmaz, Serkan Volkan, Sevinc Kant Sökel, Selcuk Kaya, Iftihar Köksal. Evaluation of clinical and laboratory predictors of fatality in patients with Hantavirus infection. J Microbil Infect Dis. 2012 Dec. 1;2(04):155-9. doi:10.5799/jmid.123129

Cited By